This is the authors' abstract. We don't add key points for this paper.
Substituted 2 H -1-benzopyran-2-ones are useful synthons and have potential as biologically active compounds. In order to characterize the transformation of benzopyran-2,5 diones with a heterocyclic hydrazine to 2 H -1-quinoline-2,5-diones and 5-hydrazono-2 H -1-benzopyran-2-ones we have studied structural parameters of the products using 2D NMR techniques in solution combined with computational tools. Molecular modeling based on experimentally determined NOE distance restraints enabled determination of solution structures of two compounds: N -[1,2,5,6,7,8-hexahydro-1-[(imidazo[1,2- b ]pyridazin-6-yl)amino]-7-methyl-2,5-dioxo-3-quinolinyl]benzamide and N -[5,6,7,8-tetrahydro-5-[(imidazo[1,2- b ]pyridazin-6-yl)hydrazono]-7-methyl-2-oxo-2 H -1-benzopyran-3-yl]benzamide.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Grdadolnik et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: